Skip to Main content Skip to Navigation
Journal articles

Signaling pathway switch in breast cancer.

Abstract : Next generation sequencing studies have drawn the general landscape of breast cancers and identified hundreds of new, actual therapeutic targets. Two major signaling pathways seem to be altered in a vast proportion of breast cancers. The PI3 kinase/AKT pathway is activated and the JUN/MAPK pathway is repressed. Via the regulation of the cell cycle this metabolic switch impacts on the balance between self-renewal, proliferation and differentiation of the tumor-initiating cells.
Document type :
Journal articles
Complete list of metadata

Cited literature [12 references]  Display  Hide  Download
Contributor : Ed. BMC Connect in order to contact the contributor
Submitted on : Monday, July 15, 2013 - 9:09:07 PM
Last modification on : Tuesday, April 12, 2022 - 4:12:13 PM
Long-term archiving on: : Wednesday, October 16, 2013 - 4:22:11 AM





Arnaud Guille, Max Chaffanet, Daniel Birnbaum. Signaling pathway switch in breast cancer.. Cancer Cell International, BioMed Central, 2013, 13 (1), pp.66. ⟨10.1186/1475-2867-13-66⟩. ⟨inserm-00844782⟩



Record views


Files downloads